Tag:
Novo Nordisk
Latest Headlines
Latest Headlines
Novo confident that it can crack blockbuster oral insulin market
Novo Nordisk says it's willing to bet $2 billion that it can score a mega-blockbuster success in the field.
Reuters: Drugmakers crafting emergency plan for Greece
Drugmakers are putting together a plan for how to keep medications flowing to Greece if the economy collapses and payments become uncertain.
Novo inks $100M deal for delivery tech
Denmark's Novo Nordisk has signed a licensing deal worth up to $100 million with drug delivery firm Caisson Biotech.
Growing Novo Nordisk inks $100M tech deal, boasts of blockbuster hopefuls
The pharma company ($NVO) has just struck a $100 million licensing deal on new drug delivery technology as its chief scientific officer reviews potential blockbusters in the pipeline with Reuters .
UPDATED: Novo Nordisk hiring R&D, other workers in U.S. recruitment blitz
Novo Nordisk says it plans to boost its U.S. workforce almost 15% this year amid growth in the Danish drugmaker's diabetes business.
Novo Nordisk, Oxford University seeking inflammation markers
A collaboration between Novo Nordisk and Oxford University could lead to new biomarkers and treatments for rheumatoid arthritis and other inflammatory diseases.
Novo Nordisk, Public Citizen duke it out over Victoza
A request to the FDA by advocacy group Public Citizen to pull the Victoza diabetes treatment threw Novo Nordisk's shares for a loop early Friday.
Biopharma giants call on FDA to demand tough standards for biosimilars
Some of their greatest concerns reflected some clear anxieties about the eventual arrival of cheaper competition.
Novo: Delivery devices could make biosimilars unsafe
The FDA's draft guidance for biosimilars allows drugs to use different delivery devices than initial reference products, but a Novo exec said that could make them unsafe.
Victoza gets superior-to-Januvia data added to label
The change comes after a study showed Novo's drug outperformed Merck's at controlling blood sugar and helping patients lose weight.
